

















The women's health technology sector has experienced significant market volatility, with many companies forced to pivot their business models, target markets, or service delivery approaches in response to changing investor sentiment, regulatory challenges, and market dynamics. These strategic pivots often involve fundamental shifts from clinic-based models to cloud-enabled platforms, direct-to-consumer approaches, or hybrid care delivery systems that can scale more efficiently while maintaining clinical quality.
Understanding how women's health companies successfully navigate these pivots provides critical insights for the broader femtech ecosystem. The challenge lies in maintaining clinical efficacy and regulatory compliance while transitioning to more scalable, technology-enabled models that can achieve sustainable growth in an increasingly competitive market environment.
Join us to discuss: